Using Gene Editing to Establish a Safeguard System for Pluripotent Stem-Cell-Based Therapies

A major challenge in using human pluripotent stem cells (hPSCs) in therapy is the risk of teratoma formation due to contaminating undifferentiated stem cells. We used CRISPR-Cas9 for in-frame insertion of a suicide gene, iC9, into the endogenous SOX2 locus in human embryonic stem cell (ESC) line H1...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:iScience
Auteurs principaux: Wu, Youjun, Chang, Tammy, Long, Yan, Huang, He, Kandeel, Fouad, Yee, Jiing-Kuan
Format: Artigo
Langue:Inglês
Publié: Elsevier 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6909005/
https://ncbi.nlm.nih.gov/pubmed/31821946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2019.11.038
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires